Pediatric Clinical Trials - ClinicalTrials.eu

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

Safety and Efficacy of Intrathecal BIIB115 in Infants with Spinal Muscular Atrophy Previously Treated with Onasemnogene Abeparvovec

Not yet recruiting

3 1 1
Investigated Diseases:
- Spinal muscular atrophy
Investigated Drugs:
- BIIB115
+4
Evaluation of 68Ga-FAPI-46 and Fluor-18-FDG PET/MRI in Paediatric Sarcoma Patients

Not yet recruiting

2 1 1 1
Investigated Diseases:
- Sarcoma
Investigated Drugs:
- Fludeoxyglucose (18F)
- (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
Study of MDMA hydrochloride therapy in adolescents aged 16‑18 with treatment‑resistant post‑traumatic stress disorder

Not yet recruiting

2 1 1
Investigated Diseases:
- Post-traumatic stress disorder
Investigated Drugs:
- Midomafetamine Hydrochloride
Phase 3 study of mitapivat for effectiveness and safety in children with non‑transfusion‑dependent alpha or beta thalassemia

Not yet recruiting

3 1
Investigated Drugs:
- Mitapivat
Surgery versus Lauromacrogol 400 injection for superficial labial venous malformations in children and adults: a randomized controlled trial

Not yet recruiting

3 1 1 1
Investigated Diseases:
- Malformation venous
Investigated Drugs:
- Lauromacrogol 400
Phase I/II Study of Dinutuximab Beta, Irinotecan, and Sirolimus in Children, Adolescents, and Adults with Relapsed or Refractory Bone Sarcoma

Not yet recruiting

1 1 1 1
Investigated Drugs:
Phase 3 Study of Mitapivat to Reduce Transfusions in Children with Alpha or Beta Transfusion‑Dependent Thalassemia

Not yet recruiting

3 1
Investigated Drugs:
- Mitapivat
Phase 3 Study of Gildeuretinol Acetate (ALK‑001) to Assess Safety and Efficacy in Slowing Progression of Stargardt Disease in Adults

Not yet recruiting

3 1
Investigated Diseases:
- Stargardt’s disease
Safety of PF-07872412 versus 20‑valent pneumococcal conjugate vaccine in healthy infants for prevention of pneumococcal disease

Not yet recruiting

3 1 1 1
Investigated Drugs:
+1
Study of atrasentan in children aged 2 to <18 years with primary IgA nephropathy to evaluate proteinuria reduction, safety and tolerability

Not yet recruiting

3 1 1
Investigated Diseases:
- IgA nephropathy
Investigated Drugs:
- Atrasentan Hydrochloride

Opportunities for Healthy Volunteers

Matched clinical trials

We use cookies